EnteroMedics to Present at the 2008 Morgan Stanley Global Healthcare Unplugged Conference.ST. PAUL St. Paul as a missionary he fearlessly confronts the “perils of waters, of robbers, in the city, in the wilderness.” [N.T.: II Cor. 11:26] See : Bravery , Minn. -- EnteroMedics Inc. (NASDAQ NASDAQ in full National Association of Securities Dealers Automated Quotations U.S. market for over-the-counter securities. Established in 1971 by the National Association of Securities Dealers (NASD), NASDAQ is an automated quotation system that reports on : ETRM ETRM Energy Trading and Risk Management ETRM Enterprise Technology Reference Model (Massachusetts) ) announced today that Mark B. Knudson, Ph.D., President and Chief Executive Officer, is scheduled to present at the 2008 Morgan Stanley Global Healthcare Unplugged Conference in Key Biscayne, Florida This article is about the village named Key Biscayne. For the island of the same name, see Key Biscayne. Key Biscayne is a village in Miami-Dade County, Florida, United States. The population was 10,507 at the 2000 census. on Wednesday, April 30, 2008, at 1:40 PM EDT EDT abbr. Eastern Daylight Time EDT Eastern Daylight Time EDT n abbr (US) (= Eastern Daylight Time) → hora de verano de Nueva York EDT . The presentation will be webcast live and may be accessed by visiting EnteroMedics' website at www.enteromedics.com. A replay of the webcast will also be available upon conclusion of the presentation. Investors can access the webcast under "Press Room" in the "Investors" section of EnteroMedics' website. About EnteroMedics Inc. EnteroMedics is a development stage medical device company focused on the design and development of devices that use neuroblocking technology to treat obesity and other gastrointestinal disorders. EnteroMedics' proprietary neuroblocking technology, VBLOC[TM] vagal vagal /va·gal/ (va´gal) pertaining to the vagus nerve. va·gal adj. Of or relating to the vagus nerve. vagal pertaining to the vagus nerve. blocking therapy, is designed to intermittently block the vagus nerves vagus nerve n. Either of the tenth pair cranial nerves that originate from the medulla oblongata and supply multiple vital organs, including the lungs, heart, and gastrointestinal viscera. using high-frequency, low-energy, electrical impulses. The Food and Drug Administration recently granted Investigation Device Exemption (IDE) approval for a pivotal clinical trial of EnteroMedics' investigational Maestro[TM] System, the Company's initial product for the treatment of obesity, that delivers VBLOC Therapy. Forward-Looking Safe Harbor Safe Harbor 1. A legal provision to reduce or eliminate liability as long as good faith is demonstrated. 2. A form of shark repellent implemented by a target company acquiring a business that is so poorly regulated that the target itself is less attractive. Statement This press release contains forward-looking statements about EnteroMedics Inc. Our actual results could differ materially from those discussed due to known and unknown risks, uncertainties and other factors including our limited history of operations, our losses since inception and for the foreseeable future; our lack of regulatory approval for our Maestro[TM] System for the treatment of obesity; our inability to complete our EMPOWER pivotal trial and other clinical trials, or significant delays in the completion of our clinical trials; our ability to timely commercialize our Maestro System; our dependence on third parties to initiate and perform our clinical trials; the need to obtain regulatory approval for any modifications to our Maestro System; physician adoption of our Maestro System and VBLOC[TM] vagal blocking therapy; our ability to obtain third party coding, coverage or payment levels; ongoing regulatory compliance; our dependence on third party manufacturers and suppliers; the successful development of our sales and marketing capabilities; our ability to raise additional capital when needed; our ability to attract and retain management and other personnel and to manage our growth effectively; potential product liability claims; potential healthcare fraud and abuse claims; and our ability to obtain and maintain intellectual property protection for our technology and products. These and additional risks and uncertainties are described more fully in the Company's filings with the Securities and Exchange Commission, particularly those factors identified as "risk factors" in the Company's Form 10-K Form 10-K A report required by the SEC from exchange-listed companies that provides for annual disclosure of certain financial information. Form 10-K See 10-K. dated March 13, 2008. We are providing this information as of the date of this press release and do not undertake any obligation to update any forward-looking statements contained in this document as a result of new information, future events or otherwise. Caution-Investigational device. Limited by Federal law to investigational use. The implantation procedure and usage of the Maestro System carry some risks, such as the risk generally associated with laparoscopic Laparoscopic A minimally-invasive surgical or diagnostic procedure that uses a flexible endoscope (laparoscope) to view and operate on structures in the abdomen. Mentioned in: Obstetrical Emergencies procedures and those related to treatment as described in the Empower clinical trial informed consent. |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion